REVIEW article

Front. Immunol.

Sec. Viral Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1593885

This article is part of the Research TopicThromboinflammation in COVID-19: Unraveling Pathomechanisms and Post-Infection SequelaeView all 14 articles

COVID-19: A Vascular Nightmare Unfolding

Provisionally accepted
Qinan  YinQinan Yin1Youjin  HuangYoujin Huang2Hulin  WangHulin Wang1Yin  WangYin Wang1Xuefei  HuangXuefei Huang2Yujie  SongYujie Song2Bian  YuanBian Yuan1*YUEYUAN  WANGYUEYUAN WANG1*Lizhu  HanLizhu Han1*
  • 1Department of pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
  • 2Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan Province, China

The final, formatted version of the article will be published soon.

The emergence of COVID-19 has been associated with an increased risk of arteriovenous thrombosis, with immune inflammation playing a significant role in the pathogenesis of thrombosis. Numerous drug-related clinical trials have been undertaken to prevent thrombosis, and guidelines for its prevention and treatment are continuously evolving as our understanding of the disease progresses. This article provides a comprehensive review of the mechanisms underlying thrombosis in COVID-19 patients, as well as the advancements in clinical trials and guidelines for thrombosis prevention with pharmacological interventions.

Keywords: COVID-19, Thrombosis, Mechanism, anticoagulation, Vaccine

Received: 17 Mar 2025; Accepted: 10 Jul 2025.

Copyright: © 2025 Yin, Huang, Wang, Wang, Huang, Song, Yuan, WANG and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Bian Yuan, Department of pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
YUEYUAN WANG, Department of pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
Lizhu Han, Department of pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.